VIMAL KUMAR NAIR, PhD Curriculum Vitae
Apt No:. 702
Bryan, TX 77801
Email: *****.******@*****.***
Ph No: 858-***-****
Seeking a challenging and responsible position in the pharmaceutical and biotechnology in-
dustry to utilize my education and experience
Education and Research Experience:
5/2012-present: Postdoctoral Research Associate, Texas A & M University, College
Station, TX (Advisor: Dr Romo/Luis)
Identification and screening of bioactive phytochemicals using HPLC-MS & MS/MS
techniques. By using HPLC MS/MS profiling, 80% of the compounds from the crude ex-
tract has been identified without the need for purification, which makes it a useful tool for
screening and dereplication.
Isolation and structure elucidation of secondary metabolites from Mormordica Charantia
and other medicinal plants for anticancer drug discovery using combination of MS and
NMR techniques.
Synthesis of Piperlongumin (PL) analogs as STAT3 inhibitors
Identification of the metabolites involves the spectroscopic techniques using NMR, MS,
GCMS, UV-VIS, IR and classical wet chemical techniques. Troubleshoot and mainte-
nance of analytical instruments as needed.
3/2011-4/2012: Post-doctoral research, Scripps Institution of Oceanography,
La Jolla CA (Advisor: Prof William Fenical)
The project involved structure elucidation of novel natural products from marine microorganisms
by using NMR spectroscopy, LCMS, HPLC, synthesis and purification of compounds by bioassay
guided silica gel chromatography/RP-18 followed by HPLC.
1
10/2007-10/2010 Ph.D. (Chemistry); University of Göttingen, Germany (Advisor:
Prof Hartmut Laatsch)
PhD Thesis: Indole alkaloids as potential leads in drug discovery and further secondary metabolites from
terrestrial and marine bacteria. 2010, University of Göttingen, Germany.
Grade: Magna Cum Laude [http://webdoc.sub.gwdg.de/diss/2012/nair/nair.pdf]
MSc, Organic Chemistry, 2001-2003, University of Mumbai, India
MS Thesis: Isolation and structure elucidation of natural products from terrestrial and marine bacteria
BSc, Chemistry, 1998-2001, University of Mumbai, India
Industry Experience:
12/2003-03/2007 Aurigene Discovery Technologies Limited, [a subsidiary of Dr.
Reddy’s Laboratories, Bangalore, India]
Worked on drug discovery programs for small molecule inhibitors targeted for kinases such as
Aurora kinase, CDK and tyrosine kinases.
Synthesized 4-methoxy quinazoline scaffold and their libraries for structure activity relationship
against VEGF and Aurora kinases.
Synthesized 4 and 6 Acetyl Benzoxazolone and Benzothiazole scaffolds respectively. These reac-
tions were carried using Fries-rearrangement. The structure activity relationship was carried out to
determine their activity against CDK and Aurora kinases.
Synthesized Vasicinone and their libraries targeted against Aurora kinase. Efforts were directed to
make the molecule a potential drug candidate by lowering its IC50 to a single digit nano molar.
Awards and Achievements
2007-2010 DAAD (German Academic Exchange Service) Award (3-year PhD Fellowship)
2009 Jung Chemie forum presentation Bis and Tris indole alkaloids from Antartica
2010 Blaubeuren Tagungszentrum Naturstoffe (Conference for Natural products in Blaubeuren,
Germany)
2
Publications :
1. Lucknolide A and B, tricyclic ketal-lactone metabolites from terrestrial Streptomyces sp.
Prem P Yadav, Vimal Nair, Birger Dittrich, Anja Schueffler and Hartmut Laatsch, 2010,
Organic Letters, 12(17), pp 3800–3803 http://pubs.acs.org/doi/pdf/10.1021/ol1014703
2. Rare Prenylated Isoflavones from Tephrosia calophylla
Seru Ganapaty*, Vimal Nair, D. Rama Devi, Steve Thomas Pannakal, Hartmut Laatsch, Birger
Dittrich; Natural Product Communications Vol. 8, 2013
3. The Effect of Exogenous Amylolytic Enzymes on the Accumulation of Chlorogenic Acid Isomers
in Wounded Potato Tubers
Ana Mariel Torres-Contreras, Vimal Nair, Luis Cisneros-Zevallos, and Daniel A. Jacobo-
Velázquez. J. Agric. Food Chem., 2014, 62 (31), pp 7671–7675
http://pubs.acs.org/doi/pdf/10.1021/jf5026983
4. Plants as biofactories: Stress-induced production of chlorogenic acid isomers in potato tubers as
affected by wounding intensity and storage time. Ana Mariel Torres-Contreras, Vimal Nair, Luis
Cisneros-Zevallos, Daniel A. Jacobo-Velázquez. Industrial crops, 2014, 62, 61–66
http://www.sciencedirect.com/science/article/pii/S0926669014004981
5. Screening Clitoria ternatea extract for Protection against LPS-induced Inflammation in Macro-
phage cells and Selectivity to Cyclooxygenase-2 (COX-2) Activity.
Vimal Nair, Elisa Schreckinger, Woo Young Bang, Ricardo Elesbao Alves, Luis Cisneros-
Zevallos, Journal of Agriculture and Food Chemistry, 2015 (accepted).
6. Anti-proliferative natural products from the flesh of Mormodica charantia (Bitter Melon), Vimal
Nair, Marvin J Meyers, Robert Steele, Ken Hull, Daniel Romo, Ratna B Ray 2015 Journal of-
Food Science. (in revision)
7. Identification of Cyclooxygenase-2 (COX-2) Inhibitors from Acerola (Malpighia emarginata) Us-
ing a Combined Assay-guided Fractionation and Drug affinity Responsive Target Stability
(DARTS) methods. Vimal Nair, Elisa Schreckinger, Woo Young Bang, Ricardo Elesbao Alves,
Luis Cisneros-Zevallos, Plos One, 2015 (in preparation).
International conference Posters
1. INDOLE ALKALOIDS FROM ANTARCTIC DEEP ICE Streptomyces sp.
Vimal Nair, Imelda Schuhmann, Heinz H. Fiebig, Elisabeth Helmke and Hartmut Laatsch 14th
International Symposium on Marine Natural Products / 8thEuropean Conference on Marine Natu-
ral Products, 2013, http://www.manapro2013.com/
2. NEW BROMOINDOLE DERIVATIVES FROM A MARINE-DERIVED Streptomyces
Vimal Nair, Birger Dittrich, Elisabeth Helmke, Hartmut Laatsch, 14th International Symposium
on Marine Natural Products / 8th European Conference on Marine Natural Products, 2013.
http://www.manapro2013.com/
3
3. New oxazoline-containing tetrapeptides from a marine-derived Streptomyces sp., strain CNX-225
Marina Scopel, Vimal Nair, William Fenical, 37th Symposium on Biotechnology for Fuels and
Chemicals, Natural Product Discovery & Development in the Post Genomic Era.
http://www.simbhq.org/docs/np/NP15Program.pdf.
Teaching Activities:
Taught 2D NMR courses for graduate students as a part of PhD program for 2 semesters 2009-2010 at
University of Gӧttingen, Germany.
Languages Known
English, German, Spanish
References (available upon request)
4
Appendix
5/2012-Present: Postdoctoral research associate, Texas A & M University
HPLC/MS profiling for amazon crops: The identification of secondary metabolites from plants is an
important step in drug discovery and development. Mass spectrometry, particularly when combined with
high-performance liquid chromatography (HPLC-MS), can enable detailed structural information to be
obtained on the metabolites. The crude extracts from the plant parts, flowers etc are run for HPLC-MS
profiling to determine their MS1 and MS2 fragmentation pattern. Using this result, determination of the
structure is performed with the help of Scifinder and identify the known structur es. Unknown fragmenta-
tion pattern are further studied by NMR to determine and characterize their structure. Using HPLC
MS/MS profiling we can identify 80% of the structures from the crude extract without purifying them.
This is very useful tool for screening and dereplication. I also troubleshoot the problems involved with the
analytical instruments and am also involved in the maintenance of HPLC and LCMS. Identification of the
metabolites involves the spectroscopic techniques using NMR, MS, UV-VIS, IR and classical wet chemi-
cal techniques.
Isolation of natural product from bitter melon targeted for prostate cancer: Two new compounds,
peroxide and sterol glucoside were isolated from the fleshy part of Momordica charantia (bitter melon).
Their structures were elucidated based on spectroscopic methods. Cytotoxic activities of peroxide and
glucoside were evaluated against PC3 and Cal27 cancer cell lines. The EC50 values and the antiprolifera-
tive effects of the glucoside were comparable with that of cholesterol β-D-glucoside (GC-2) which is
structurally similar to the newly isolated glucoside.
Synthesis of Piperlongumin (PL) Analogues as STAT3 inhibitors: I am using rational drug design and
medicinal chemistry at the start to develop our lead PL compound. I have performed a small-scale struc-
ture activity relationship (SAR) study to identify key functional groups or components in PL that contri b-
ute to the observed activity. Second, based on the results, medicinal chemistry will be carried out to syn-
thesize a collection (~50) of rationally designed analogs in order to find compounds with improved activi-
ty. Third, SAR as well as quantitative SAR (QSAR) studies of these compounds will guide the next round
of compound design and synthesis.
3/2011-4/2012: Post-doctoral research, Scripps Institution of Oceanography
Project CNX026: Novel depsipeptide Thiazomide A has been isolated which belong to a thiocoraline
class compound. The strain also produced two other new lower molecular weight molecules having a 3 -
hydroxy-quinolinic acid chromophore, which appear to be lower homologs. The structures of the new
compounds were elucidated by a combination of spectral methods and by a single crystal X -ray diffrac-
tion study that provided the absolute configuration of the molecule. Thiazomide A showed significant
cytotoxicity toward HCT-116 human colon carcinoma with an IC50 of 0.5 µg/ml. Studies now in progress
are designed to determine the mechanism of action of this new compound as well as its protein target.
Project CNX225: Two new tri substituted oxazoline indole-containing peptides, 225.F1A and 225F1B,
were isolated from the fermentation broth of an actinomycete identified by phylogenetic methods as a
Streptomyces sp. (strain CNX225). The planar structures of these compounds were assigned on the basis
of 1D and 2D NMR spectroscopy and MS analyses. Further, the absolute configurations of the structure
of one of the peptides were confirmed by a single crystal X-ray diffraction study. The innovative struc-
tures of the isolated compounds open up new challenges for synthetic chemistry and modify the structures
for its probable biological targets.
5